Abstract:Abstract Introduction: We previously have identified histologic grade as an important prognostic factor for outcomes in early stage pancreatic cancer following surgical resection. In this study we investigated genes associated with histologic differentiation in early stage pancreatic cancer and their biologic relevance. Methods: We studied the gene expression profile of 61 resected primary pancreatic cancers through analysis of a custom Affymetrix microarray. Significance analysis of microarrays was used to select genes associated with histologic grade. Following identification of these genes we focused on Annexin A8 (A-A8) for further mechanistic studies. We analyzed the relationship of protein expression, tumor grade and outcomes using immunohistochemistry (IHC) in a tissue microarray (TMA) of 91 resected pancreatic cancer patients. Mechanistic studies of A-Aa8 included gene silencing using SiRNA and measurement of the cellular effects by migration, proliferation and colony formation assays. Statistical analysis was performed with Fisher's exact test, T-test and ANOVA as indicated and Cox modeling was used for survival analysis. Results: We identified 34 genes that were downregulated, and 15 genes that were upregulated as tumor grade progressed from well to moderate to poorly differentiated. Then we focused on A-A8 induction in this data set, with a 5.9 fold increased A-A8 expression from low to high grade tumors (r=0.31;p=0.019), the immunohistochemical expression of A-A8 was correlated with tumor grade in a human pancreatic tumor tissue microarray (r=0.26;p=0.014); finally high expression of A-A8 is associated with a significant decrease in 5 year survival following resection of stage I and II human pancreatic cancer by Cox model (p=0.049). Western blotting confirmed increased expression of A-A8 in human pancreatic cancer cell lines. Knockdown of A-A8 in human pancreatic cancer BXPC-3 cells with SiRNA resulted in significant decrease in cell viability (p<0.001), cell migration (2.5 vs. 0.9mm at 96h;p=0.048), and colony formation (p=0.007). Conclusions: Studying the expression profiles of primary pancreatic cancer analyzed on Affymetrix microarrays, we identified A-A8 as a gene associated with pancreatic cancer differentiation. Downregulation of A-A8 by RNA interference in pancreatic cancer cells results in growth and migration inhibition. Finally we show that high A-A8 expression is associated with poor disease outcome in pancreatic cancer patients. These results support further investigation of Annexin A8 as a potential therapeutic target and prognostic marker for human pancreatic cancer. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 710. doi:1538-7445.AM2012-710

Knockdown <i>annexin A8</i> Inhibits the Proliferation and Invasion of Cervical Cancer Cells

Annexin I and Tumor

Annexin A9 promotes cell proliferation by regulating the Wnt signaling pathway in colorectal cancer

Interference with ANXA8 inhibits the malignant progression of ovarian cancer by suppressing the activation of the Wnt/β-catenin signaling pathway via UCHL5

Decreased Expression of Annexin A1 During the Progression of Cervical Neoplasia

ANXA2 Silencing Inhibits Proliferation, Invasion, and Migration in Gastric Cancer Cells

Annexin A8 is a Prognostic Marker and Potential Therapeutic Target for Pancreatic Cancer.

Annexin A9 promotes invasion and metastasis of colorectal cancer and predicts poor prognosis

Annexin A5 suppression promotes the progression of cervical cancer

Annexin A1 promotes the progression of bladder cancer via regulating EGFR signaling pathway

AnnexinA5 Might Suppress the Phenotype of Human Gastric Cancer Cells via ERK Pathway

The Mechanism of Annexin A1 Regulating the Proliferation, Apoptosis and Migration of Bladder Cancer Cells

Annexin A7 suppresses lymph node metastasis of hepatocarcinoma cells in a mouse model

Analysis of the Expression and Prognostic Value of Annexin Family Proteins in Bladder Cancer.

Tissue Microarray Analysis Reveals Strong Clinical Evidence for a Close Association Between Loss of Annexin A1 Expression and Nodal Metastasis in Gastric Cancer

Abstract 710: Genetic Identification of Annexin-A8 As a Therapeutic Target and Prognostic Marker for Pancreatic Cancer

ANXA2 is a Potential Marker for the Diagnosis of Human Cervical Cancer

[Expression of Annexin I in Human Pancreatic Cancer and the Influence of Its Down-Regulation on Biology of This Cancer].

Annexin-1 Downregulation is Associated with Clinical Outcome in Chinese Patients with Hilar Cholangiocarcinoma

Potential prognostic and therapeutic value of ANXA8 in renal cell carcinoma: based on the comprehensive analysis of annexins family

Annexin A protein family: Focusing on the occurrence, progression and treatment of cancer.

Knockdown &lt;i&gt;annexin A8&lt;/i&gt; Inhibits the Proliferation and Invasion of Cervical Cancer Cells